Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
Oncotarget
.
2022 Aug 4:13:982.
doi: 10.18632/oncotarget.28262.
Authors
Sewanti Limaye
1
,
Prashant Kumar
2
3
4
,
Ramya Pragya
1
,
Janani Sambath
3
4
,
Darshana Patil
2
,
Ajay Srinivasan
2
,
Sachin Apurva
2
,
Navin Srivastava
2
,
Sanket Patil
2
,
Revati Patil
2
,
Vineet Datta
2
,
Dadasaheb Akolkar
2
,
Rajan Datar
2
Affiliations
1
Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
2
Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
3
Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka, India.
4
Manipal Academy of Higher Education, Manipal, Karnataka, India.
PMID:
36455294
PMCID:
PMC9359459
DOI:
10.18632/oncotarget.28262
No abstract available
Publication types
Published Erratum